With the emergence of next-generation ICIs, including lymphocyte-activation gene 3 (LAG-3) blocking antibodies such as relatlimab, the clinical relevance of accurately diagnosing ICI-IAD is expected to grow. This evidence concerns the gene LAG3 and internet addiction disorder.